drugset / Trial / NCT04540185
A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19
RandomizedParallel-groupQuadruple-blindPrevention
Summary
In this randomized double blind Phase 3 clinical trial we will study the efficacy and safety of oral polio vaccine with and without NA-831 versus placebo.
Timeline
- Start
- 2020-11-01
- Primary completion
- 2022-11-01
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CYCLO(PROLYLGLYCYL) | Small molecule | 30 mg | Oral |
| Subject | Oral Polio Vaccine | Vaccine | 0.1 ml | Oral |